CN100351385C - 用于免疫调节的疱疹病毒 - Google Patents

用于免疫调节的疱疹病毒 Download PDF

Info

Publication number
CN100351385C
CN100351385C CNB018109330A CN01810933A CN100351385C CN 100351385 C CN100351385 C CN 100351385C CN B018109330 A CNB018109330 A CN B018109330A CN 01810933 A CN01810933 A CN 01810933A CN 100351385 C CN100351385 C CN 100351385C
Authority
CN
China
Prior art keywords
virus
gene
purposes
functional
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB018109330A
Other languages
English (en)
Chinese (zh)
Other versions
CN1439056A (zh
Inventor
R·S·科芬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biovex Ltd
Original Assignee
Biovex Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovex Ltd filed Critical Biovex Ltd
Publication of CN1439056A publication Critical patent/CN1439056A/zh
Application granted granted Critical
Publication of CN100351385C publication Critical patent/CN100351385C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/763—Herpes virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/19—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/24—Antigen-presenting cells [APC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/46—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16632—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16641—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CNB018109330A 2000-04-12 2001-04-12 用于免疫调节的疱疹病毒 Expired - Fee Related CN100351385C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0009079.5A GB0009079D0 (en) 2000-04-12 2000-04-12 Herpes viruses for immune modulation
GB0009079.5 2000-04-12

Publications (2)

Publication Number Publication Date
CN1439056A CN1439056A (zh) 2003-08-27
CN100351385C true CN100351385C (zh) 2007-11-28

Family

ID=9889816

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB018109330A Expired - Fee Related CN100351385C (zh) 2000-04-12 2001-04-12 用于免疫调节的疱疹病毒

Country Status (18)

Country Link
EP (1) EP1272652B1 (cg-RX-API-DMAC7.html)
JP (2) JP2003530369A (cg-RX-API-DMAC7.html)
KR (1) KR100805771B1 (cg-RX-API-DMAC7.html)
CN (1) CN100351385C (cg-RX-API-DMAC7.html)
AT (1) ATE278795T1 (cg-RX-API-DMAC7.html)
AU (1) AU783395B2 (cg-RX-API-DMAC7.html)
BR (1) BR0109928A (cg-RX-API-DMAC7.html)
CA (1) CA2405458C (cg-RX-API-DMAC7.html)
DE (1) DE60106222T2 (cg-RX-API-DMAC7.html)
DK (1) DK1272652T3 (cg-RX-API-DMAC7.html)
ES (1) ES2230291T3 (cg-RX-API-DMAC7.html)
GB (2) GB0009079D0 (cg-RX-API-DMAC7.html)
HK (1) HK1048136B (cg-RX-API-DMAC7.html)
IL (2) IL152055A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA02010074A (cg-RX-API-DMAC7.html)
PT (1) PT1272652E (cg-RX-API-DMAC7.html)
WO (1) WO2001077358A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200207920B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7063851B2 (en) 2000-04-12 2006-06-20 Biovex Limited Herpes viruses for immune modulation
JP2004099584A (ja) 2002-05-02 2004-04-02 Keio Gijuku Hsvを用いた抗腫瘍剤
US7695725B2 (en) * 2003-02-06 2010-04-13 Aduro Biotech Modified free-living microbes, vaccine compositions and methods of use thereof
GB0317511D0 (en) 2003-07-25 2003-08-27 Biovex Ltd Viral vectors
US7842289B2 (en) 2003-12-24 2010-11-30 Aduro Biotech Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
US20100008944A1 (en) * 2005-07-29 2010-01-14 President And Fellows Of Harvard College Herpes simplex virus mutant and uses therefore
CN102146418B (zh) * 2010-02-09 2014-01-15 武汉滨会生物科技有限公司 重组ⅱ型单纯疱疹病毒载体及其制备方法、重组病毒、药物组合物及应用
CN105219739A (zh) * 2015-09-21 2016-01-06 北京神源德生物科技有限公司 重组单纯疱疹病毒及它感染和制备它的宿主细胞以及它们的应用
CN105219738A (zh) * 2015-09-21 2016-01-06 北京神源德生物科技有限公司 重组单纯疱疹病毒及它感染和制备它的宿主细胞以及它们的应用
JP7075653B2 (ja) * 2018-02-06 2022-05-26 学校法人福岡大学 αヘルペスウイルス感染を処置する方法及び医薬組成物
CN109161561A (zh) * 2018-08-09 2019-01-08 湖北科技学院 一种选择性杀灭前列腺癌细胞的新型溶瘤病毒及其构建方法
EP4511049A4 (en) * 2022-04-18 2026-04-29 Candel Therapeutics Inc COMPOSITIONS AND METHODS INTENDED FOR VIRAL VECTORS
AU2023319760A1 (en) * 2022-08-05 2025-02-13 Immvira Co., Limited Replication incompetent herpes simplex virus type 1 viral vaccine

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997013866A2 (en) * 1995-10-11 1997-04-17 University Of British Columbia Recombinant herpes virus vectors for expression in neuronal cells
WO1998004726A1 (en) * 1996-07-26 1998-02-05 Medical Research Council Hsv strain lacking functional icp27 and icp34.5 genes
WO2000008191A2 (en) * 1998-07-31 2000-02-17 Biovex Limited Herpes virus vectors for dendritic cells
CN1295612A (zh) * 1998-01-29 2001-05-16 拜奥维克斯有限公司 突变型单纯疱疹病毒及其用途
CN1310765A (zh) * 1998-05-20 2001-08-29 拜奥维克斯有限公司 突变的单纯疱疹病毒及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998174A (en) * 1997-05-12 1999-12-07 University Of Pittsburgh Of The Commonwealth System Of Higher Education Multigene vectors

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997013866A2 (en) * 1995-10-11 1997-04-17 University Of British Columbia Recombinant herpes virus vectors for expression in neuronal cells
WO1998004726A1 (en) * 1996-07-26 1998-02-05 Medical Research Council Hsv strain lacking functional icp27 and icp34.5 genes
CN1295612A (zh) * 1998-01-29 2001-05-16 拜奥维克斯有限公司 突变型单纯疱疹病毒及其用途
CN1310765A (zh) * 1998-05-20 2001-08-29 拜奥维克斯有限公司 突变的单纯疱疹病毒及其用途
WO2000008191A2 (en) * 1998-07-31 2000-02-17 Biovex Limited Herpes virus vectors for dendritic cells

Also Published As

Publication number Publication date
GB2376687B (en) 2004-06-09
GB0009079D0 (en) 2000-05-31
JP2012188440A (ja) 2012-10-04
MXPA02010074A (es) 2003-04-25
AU4672801A (en) 2001-10-23
EP1272652B1 (en) 2004-10-06
JP5543528B2 (ja) 2014-07-09
GB0224000D0 (en) 2002-11-20
BR0109928A (pt) 2003-05-27
CN1439056A (zh) 2003-08-27
WO2001077358A3 (en) 2002-03-14
HK1048136A1 (en) 2003-03-21
IL152055A (en) 2010-12-30
CA2405458A1 (en) 2001-10-18
CA2405458C (en) 2011-08-30
KR100805771B1 (ko) 2008-02-21
IL152055A0 (en) 2003-05-29
PT1272652E (pt) 2004-12-31
ATE278795T1 (de) 2004-10-15
DK1272652T3 (da) 2005-02-14
WO2001077358A2 (en) 2001-10-18
AU783395B2 (en) 2005-10-20
KR20030047883A (ko) 2003-06-18
JP2003530369A (ja) 2003-10-14
DE60106222D1 (de) 2004-11-11
DE60106222T2 (de) 2005-10-13
ZA200207920B (en) 2004-07-08
HK1048136B (zh) 2004-12-03
EP1272652A2 (en) 2003-01-08
GB2376687A (en) 2002-12-24
ES2230291T3 (es) 2005-05-01

Similar Documents

Publication Publication Date Title
US6641817B1 (en) Herpes virus vectors for dendritic cells
JP5543528B2 (ja) 免疫モジュレーション用のヘルペスウイルス
EP1346036B1 (en) Helper virus-free herpes virus amplicon particles and uses thereof
AU2002246625A1 (en) Helper virus-free herpes virus amplicon particles and uses thereof
US7118755B2 (en) Herpes viruses for immune modulation
US7063851B2 (en) Herpes viruses for immune modulation
AU2006200203B2 (en) Herpes viruses for immune modulation
MXPA01001123A (en) Herpes virus vectors for dendritic cells

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20071128

Termination date: 20190412

CF01 Termination of patent right due to non-payment of annual fee